Spero Therapeutics, Inc. (SPRO)
2.195
+0.02
(+1.15%)
USD |
NASDAQ |
Mar 02, 16:00
2.195
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics EPS Diluted (Quarterly) : -0.1312 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Cassava Sciences, Inc. | -0.2237 |
| Alpha Teknova, Inc. | -0.0889 |
| Pyxis Oncology, Inc. | -0.3517 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.382M |
| Revenue (Quarterly) | 3.048M |
| Total Expenses (Quarterly) | 10.43M |
| Enterprise Value | 76.99M |
| Profit Margin (Quarterly) | -242.2% |
| Earnings Yield | -36.21% |
| Normalized Earnings Yield | -35.22 |